Recombinant Human LDHAL6A Protein，His

LDHAL6A (L-lactate dehydrogenase, on the other hand, was identified as a critical enzyme implicated in the oxidation of lactate to pyruvate, a key step in metabolic pathways relevant to cellular respiration and energy production. The protein has garnered interest due to its potential roles in various physiological and pathological processes, including cancer metabolism and tissue oxygenation. Preliminary studies suggest that LDHAL6A may play a role in regulating lactate levels and thus influence the tumor microenvironment and cancer cell proliferation. Given the increasing evidence linking altered lactate metabolism to various diseases, including metabolic disorders and cancers, researchers have begun exploring LDHAL6A as a potential therapeutic target or biomarker. The production of recombinant LDHAL6A protein allows for detailed biochemical analyses and structural studies, facilitating the understanding of its function and regulation. Additionally, studying the enzyme's activity and interactions with other metabolic pathways could provide insights into developing targeted therapies or diagnostic tools. Consequently, LDHAL6A is positioned as a promising candidate for further investigation in translational research aimed at addressing metabolic disruptions in cancer and other diseases. The ongoing research efforts focus on characterizing the recombinant protein's activity, stability, and potential interactions, which could ultimately contribute to novel therapeutic approaches in the fight against metabolic-related diseases.